Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone

Diabetology and Metabolic Syndrome

Volumn 3, Issue 1, 2011, Pages

  Håkansson, Joakim ^a,b   Eliasson, Björn ^c   Smith, Ulf ^c   Enerbäck, Sven ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Pharmasurgics AB   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; RNA; ROSIGLITAZONE; TRANSCRIPTION FACTOR FOXC2;

ABDOMINAL FAT; ADIPOCYTE; ARTICLE; BIOGENESIS; BIOPSY; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DNA DETERMINATION; DRUG RESPONSE; FEMALE; GENE EXPRESSION; HEALTH SERVICE; HUMAN; MALE; MITOCHONDRIAL GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RNA ANALYSIS; SUBCUTANEOUS FAT;

EID: 81255178486     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-3-32     Document Type: Article

References (22)

1. Recent findings concerning thiazolidinediones in the treatment of diabetes. Boden G, Zhang M, Expert Opin Investig Drugs 2006 15 243 250 10.1517/13543784.15.3.243 16503761 (Pubitemid 43338145)
2. The Clinical Significance of PPAR Gamma Agonism. Campbell IW, Curr Mol Med 2005 5 349 363 10.2174/1566524053766068 15892654 (Pubitemid 40663140)
3. Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, et al. Biochem Pharmacol 2005 70 177 188 10.1016/j.bcp.2005.03.033 15925327 (Pubitemid 40814400)
4. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Fukui Y, Masui S, Osada S, Umesono K, Motojima K, Diabetes 2000 49 759 767 10.2337/diabetes.49.5.759 10905484 (Pubitemid 30339991)
5. Mitochondrial transcription factor A (mtTFA) and diabetes. Choi YS, Kim S, Pak YK, Diabetes Res Clin Pract 2001 54 Suppl 2 3 9 11733104
6. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Ekstrand MI, Falkenberg M, Rantanen A, Park CB, Gaspari M, et al. Hum Mol Genet 2004 13 935 944 10.1093/hmg/ddh109 15016765 (Pubitemid 38628429)
7. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, et al. Nat Genet 1998 18 231 236 10.1038/ng0398-231 9500544 (Pubitemid 28117260)
8. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Virbasius JV, Scarpulla RC, Proc Natl Acad Sci USA 1994 91 1309 1313 10.1073/pnas.91.4.1309 8108407 (Pubitemid 24059000)
9. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P, et al. Cell 2001 106 563 573 10.1016/S0092-8674(01)00474-3 11551504 (Pubitemid 32879318)
10. Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases in intramuscular fatty acyl CoA and insulin resistance. Kim JK, Kim HJ, Park SY, Cederberg A, Westergren R, et al. Diabetes 2005 54 1657 1663 10.2337/diabetes.54.6.1657 15919786 (Pubitemid 40770755)
11. Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Yang X, Enerback S, Smith U, Obes Res 2003 11 1182 1191 10.1038/oby.2003.163 14569043 (Pubitemid 41127371)
12. The adipocyte-expressed forkhead transcription factor Foxc2 regulates metabolism through altered mitochondrial function. Lidell ME, Seifert EL, Westergren R, Heglind M, Gowing A, et al. Diabetes 2011 60 427 435 10.2337/db10-0409 21270254
13. Cardiovascular manifestations of insulin resistance. Chahwala V, Arora R, Am J Ther 2009 16 14 28 10.1097/MJT.0b013e3180a724b3 19114874
14. Effects of thiazolidinediones on blood pressure. Giles TD, Sander GE, Curr Hypertens Rep 2007 9 332 337 10.1007/s11906-007-0060-0 17686386 (Pubitemid 47377033)
15. Diabetes mellitus and macrovascular disease: mechanisms and mediators. Boyle PJ, Am J Med 2007 120 12 17 17826041
16. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Bogacka I, Xie H, Bray GA, Smith SR, Diabetes 2005 54 1392 1399 10.2337/diabetes.54.5.1392 15855325 (Pubitemid 40586669)
17. Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Sears DD, Hsiao G, Hsiao A, Yu JG, Courtney CH, et al. Proc Natl Acad Sci USA 2009 106 18745 18750 10.1073/pnas.0903032106 19841271
18. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Koh EH, Park JY, Park HS, Jeon MJ, Ryu JW, et al. Diabetes 2007 56 2973 2981 10.2337/db07-0510 17827403 (Pubitemid 350223632)
19. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, et al. Int J Obes (Lond) 2007 31 1302 1310 10.1038/sj.ijo.0803567 (Pubitemid 47172612)
20. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, et al. Proc Natl Acad Sci USA 2003 100 8466 8471 10.1073/pnas.1032913100 12832613 (Pubitemid 36842568)
21. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Rong JX, Qiu Y, Hansen MK, Zhu L, Zhang V, et al. Diabetes 2007 56 1751 1760 10.2337/db06-1135 17456854 (Pubitemid 47025441)
22. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, et al. Clin Chem 2004 50 166 174 10.1373/clinchem.2003.024802 14709644 (Pubitemid 38125714)